Phenylbutazone, a New Long-Acting Agent that can Improve the Peptide Pharmacokinetic Based on Serum Albumin as a Drug Carrier. [electronic resource]
- Chemical biology & drug design 06 2016
- 936-45 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1747-0285
10.1111/cbdd.12726 doi
Animals Drug Carriers--chemistry Fatty Liver--blood Humans Male Mice Mice, Inbred ICR Mice, Obese Phenylbutazone--chemistry Receptors, Neuropeptide Y--agonists Serum Albumin--chemistry